Tag: pembrolizumab

Oct 04, 2026

• oncology
• immunotherapy
• mRNA-vaccine
• melanoma
• adjuvant-therapy
• keytruda
• moderna
• merck
• immune-checkpoint-inhibitor
• pembrolizumab

Oct 04, 2026

• oncology
• immunotherapy
• mRNA-vaccine
• melanoma
• pembrolizumab
• keytruda
• moderna
• merck
• adjuvant-therapy
• pd-1-inhibitor

Oct 04, 2026

• resected-melanoma
• adjuvant-therapy
• mrna-vaccine
• moderna
• merck
• keytruda
• pembrolizumab
• intismeran-autogene